Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients.

Ahn, Jee Hyun; Choi, Soon Bo; Park, Jung Min; Kim, Jee Ye; Park, Hyung Seok; Kim, Seung Il; Park, Byeong-Woo; Park, Seho.

Afiliação

Ahn JH; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Choi SB; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Park JM; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Kim JY; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Park HS; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Kim SI; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Park BW; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.
Park S; Division of Breast Surgery, Department of Surgery, College of Medicine, Yonsei University, Seoul 03722, Korea.

Cancers (Basel) ; 13(19)2021 Oct 06.

Article em En | MEDLINE | ID: mdl-34638491